Articles From: Franklin Resources, Inc. to Announce First Quarter Results on January 30, 2015 to Patent Trial and Appeal Board Denies IPR Petition Aimed at ParkerVision '342 Patent


http://media.marketwire.com/attachments/200910/443789_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168210&ProfileId=051205&sourceType=1 SAN MATEO, CA --
Sign-up for Franklin Resources, Inc. to Announce First Quarter Results on January 30, 2015 investment picks
SALT LAKE CITY , Jan.
Sign-up for FX Energy Announces Sidetrack at Zaniemysl-3k Well investment picks
2015/1/8
G&K Services, Inc. (NASDAQ: GK) will report its fiscal 2015 second quarter results on Tuesday, January 27, 2015, before the market opens.
Sign-up for G&K Services to Report Fiscal 2015 Second Quarter Financial Results investment picks
2015/1/8
By Josh Beckerman General Mills Inc. said it plans to eliminate another 500 jobs with the closures of two Pillsbury dough factories, adding to the roughly 1,400 job cuts it announced last year as it tries to improve profitability amid lackluster industry sales.
Sign-up for General Mills Plans to Close Two Plants -- Update investment picks
2015/1/8
By Jeff Bennett General Motors Co.
Sign-up for GM CEO: 2015 US Light-Vehicle Industry Sales Seen Between 16.5 Million-17 Million investment picks
The head of national sales for Groupon Inc. (GRPN) has stepped down from his day-to-day role at the company to pursue an entrepreneurial venture, Re/code reported, citing a source familiar with the matter.
Sign-up for Groupon sales head steps down: Re/code investment picks
2015/1/8
Highlights Recruitment completed rapidly into Part A of Phase 2/3 trial in Dravet syndrome Part B of Phase 2/3 trial and second Phase 3 trial in Dravet syndrome to start Q1 2015 Top line Phase 3 data expected by the end of 2015 Two Phase 3 trials in Lennox-Gastaut syndrome to start Q1 2015 220 children currently on treatment in U.S. expanded access program, additional data expected during H1 2015 Phase 2 CBDV epilepsy trial due to commence Q1 2015 U.S. Notice of Allowance received for patent covering use of CBD in treatment of partial seizures -Conference call and webcast at 8:00 a.m. EST, 1:00 p.m. GMT to discuss this and other press release issued today- LONDON, Jan.
Sign-up for GW Pharmaceuticals Provides Update on Epidiolex(R) Program in Treatment Resistant Childhood Epilepsies investment picks
2015/1/8
LONDON--Retailer Halfords Group PLC (HFD.LN) said Thursday that Chief Executive Officer Matt Davies has resigned to take up a position at supermarket chain Tesco PLC (TSCO.LN). Mr.
Sign-up for Halfords CEO Matt Davies to Join Tesco investment picks
ROCHESTER, Minn., Jan.
Sign-up for HMN Financial, Inc. to Redeem All Outstanding Shares of Preferred Stock investment picks
2015/1/8
By Angela Chen Infinity Pharmaceuticals Inc. won't continue developing its rheumatoid-arthritis treatment after the drug, called duvelisib, didn't meet its goal in a clinical trial.
Sign-up for Infinity to stop development of rheumatoid-arthritis treatment investment picks
InnerWorkings, Inc. (NASDAQ: INWK ), a global marketing supply chain company, will announce its fourth quarter and full year 2014 results after financial markets close on Thursday, February 12, 2015.
Sign-up for InnerWorkings to Announce Fourth Quarter and Full Year 2014 Financial Results on February 12, 2015 investment picks
2015/1/8
WASHINGTON--Congress moved closer to a likely approval of the Keystone XL pipeline Thursday, as a Senate panel advanced the legislation and the House prepared for a vote on Friday.
Sign-up for Keystone XL Moves Closer to Congressional Approval investment picks
2015/1/8
COLUMBUS, Ohio , Jan.
Sign-up for L Brands Reports December 2014 Sales investment picks
2015/1/8
Partnership provides business owners access to affordable credit and financial education SAN FRANCISCO , Jan.
Sign-up for Lending Club and SCORE Partner to Support Small Businesses investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that its partner Melinta Therapeutics reported positive top-line results from the first of two Phase 3 PROCEED studies (study RX-3341-302, NCT01811732) to evaluate delafloxacin, an investigational fluoroquinolone, compared with vancomycin + aztreonam for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI). Delafloxacin met the study’s primary objective endpoint of a reduction in the measurement of lesion erythema at the primary infection site at 48- to- 72 hours, the endpoint required by the U.S. Food and Drug Administration (FDA). Delafloxacin also was comparable to vancomycin in the study’s secondary endpoints, including investigator assessment of signs and symptoms of infection at the follow-up visit, a metric required by the European Medicines Agency (EMA).
Sign-up for Ligand Partner Melinta Therapeutics Reports Positive Phase 3 Results for Captisol-enabled™ Delafloxacin IV investment picks
Lighting Science Group Corporation (OTCQB: LSCG) is pleased to announce the launch of the new Vintage™ Filament Series of LED lamps.
Sign-up for Lighting Science Group Unveils Much Anticipated Vintage Filament Series LED Lamps investment picks
2015/1/8
By Maria Armental Macy's Inc. announced plans on Thursday to change how it stocks and sells clothing and other items saying it is trying to respond to a shift in consumer shopping.
Sign-up for Macy's Moves to Reset Business To Reflect Changing Shopper -- 2nd Update investment picks
Tyler Technologies, Inc. (NYSE: TYL) has signed an agreement with Marin County, California, for Tyler’s Munis ® enterprise resource planning (ERP) solution.
Sign-up for Marin County, California, Signs $8 Million ERP Agreement with Tyler Technologies investment picks
Marsh & McLennan Agency LLC (MMA), a subsidiary of Marsh, a global leader in insurance broking and risk management, today announced that it has acquired The Benefit Planning Group, Inc. , a Durham, North Carolina-based employee benefit consulting firm.
Sign-up for Marsh & McLennan Agency Acquires The Benefit Planning Group investment picks
2015/1/8
Morgan Stanley today announced that Morgan Stanley Credit Partners, which is part of the Firm’s Merchant Banking & Real Estate Investing business, has raised aggregate commitments of approximately $1 billion for Morgan Stanley Credit Partners II, L.P., the Firm’s second investment vehicle targeting corporate mezzanine debt and related instruments issued by middle market companies in North America and Western Europe.
Sign-up for Morgan Stanley Raises $1 Billion for Second Mezzanine Debt Fund investment picks
Myers Industries, Inc. (NYSE:MYE), an international manufacturer of polymer products and wholesale distributor servicing the under vehicle service industry in the U.S., announced today that it has entered into a definitive agreement to sell its Lawn & Garden business for $115 million to an entity controlled by Wingate Partners V, L.P., a Dallas, TX based private equity firm.
Sign-up for Myers Industries Enters into Definitive Agreement to Sell Its Lawn & Garden Business investment picks
Charles & Colvard, Ltd.
Sign-up for Neal Goldman Elected Executive Chairman of Charles & Colvard’s Board of Directors investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168219&ProfileId=051205&sourceType=1 NEWPORT, NH --
Sign-up for New Hampshire Thrift Bancshares, Inc. Announces Quarterly Dividend and Annual Meeting Date investment picks
2015/01/08
There were many surprises in 2014's bond markets, but a few managers got it right.
Sign-up for Nominees for 2014 Fixed-Income Fund Manager of the Year investment picks
JACKSONVILLE, Fla., Jan.
Sign-up for Patent Trial and Appeal Board Denies IPR Petition Aimed at ParkerVision '342 Patent investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Franklin Resources, Inc. to Announce First Quarter Results on January 30, 2015 to Patent Trial and Appeal Board Denies IPR Petition Aimed at ParkerVision '342 Patent
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent